mayo clinic glp 1 program How GLP-1s affect older adults Mayo Clinic researchers have developed

Description

Mullins RJ, Mustapic M, Chia CW, Carlson O, Gulyani S, Tran J, et al

After injection, Semaglutide GLP-1 binds to GLP-1 receptors in the pancreas and brain, triggering physiological changes that support weight loss

Yet pre-existing leptin receptor resistance often persists, creating a physiological environment that actively resists further weight loss

The big issue is how long to continue these medications

The most common side effects of Wegovy may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat